Repligen (RGEN) Other financing activities (2010 - 2026)

Repligen (RGEN) posted quarterly Other financing activities of $94000.0 for Q2 2026, down 90.91% quarter-over-quarter from $1.0 million in Q4 2025.

Repligen (RGEN) Other financing activities (2010 - 2026) Analysis & Trends

Repligen (RGEN) has reported Other financing activities for 17 consecutive years, with $94000.0 the latest figure, recorded in Q2 2026.

In Q2 2026, Other financing activities changed N/A year-over-year to $94000.0; the TTM figure through Jun 2026 stood at $1.8 million (down 54.51% YoY), while the FY2025 annual figure was $3.2 million, down 26.04% from the prior year.
Other financing activities declined to $94000.0 in Q2 2026 per RGEN's latest filing, from $1.0 million in the prior quarter.
Across five years, Other financing activities topped out at $2.3 million in Q3 2022 and bottomed at $29000.0 in Q1 2023.
Historically, Other financing activities has averaged $771687.5 across 5 years, with a median of $699000.0 in 2023.
Annual changes were most pronounced in 2023 — Other financing activities slumped 90.2% — and 2024, when it soared 3158.62%.
Repligen's Other financing activities stood at $923000.0 in 2022, then fell by 21.99% to $720000.0 in 2023, then soared by 167.78% to $1.9 million in 2024, then slumped by 46.37% to $1.0 million in 2025, then sank by 90.91% to $94000.0 in 2026.
Business Quant data shows RGEN's Other financing activities at $94000.0 in Q2 2026, $1.0 million in Q4 2025, and $678000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Intuitive Surgical	134.13 Bn	128.91 Bn	1.96 Bn
2	Becton Dickinson	52.76 Bn	51.90 Bn	2.32 Bn
3	Alcon	35.81 Bn	34.46 Bn	1.68 Bn
4	Resmed	33.72 Bn	32.25 Bn	861.22 Mn
5	Medline	29.38 Bn	26.70 Bn	2.22 Bn
6	West Pharmaceutical Services	25.00 Bn	24.57 Bn	329.20 Mn
7	Solventum	15.46 Bn	15.06 Bn	1.29 Bn
8	Cooper Companies	14.88 Bn	14.74 Bn	735.40 Mn
9	Baxter International	13.58 Bn	11.43 Bn	1.03 Bn
10	Repligen	10.25 Bn	9.24 Bn	110.04 Mn

Download Data